financetom
Business
financetom
/
Business
/
What's Going On With Ford Shares?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Ford Shares?
Aug 8, 2024 12:20 PM

Ford Motor Co ( F ) shares are trading higher by 3.79% to $10.14 during Thursday’s session amid overall market strength. Major indexes are higher following better-than-expected U.S. jobs data.

The decline in jobless claims suggests that the labor market is stronger than anticipated, reducing fears of an imminent recession. A healthier economy generally supports consumer spending, which is crucial for companies like Ford that rely on strong consumer demand for vehicles. This improved economic outlook is boosting investor confidence across the market, including in non-tech sectors like the automotive industry.

The reduction in recession fears and the accompanying rise in Treasury yields Thursday indicates that the market is adjusting its expectations for future interest rate cuts. A lower likelihood of aggressive rate cuts suggests that the Federal Reserve may not need to act as aggressively to stimulate the economy.

For companies like Ford, which require substantial capital investment, stable or slightly higher interest rates can be beneficial as they signal a more predictable economic environment and reduce the risk of inflationary pressures.

Read Also: Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar

Is F A Good Stock To Buy?

Wall Street analysts view Ford Motor ( F ) on the whole as a Outperform, given the history of coverage over the past three months. Mark Delaney from Goldman Sachs in Ford Motor ( F ) is the most bearish, expecting a 14.29% fall in the stock in the coming year.

But looking at how the market as a whole thinks of the stock, you can reference historical price action for views on whether investors feel strongly about the stock one way or another. In the past 3 months, Ford Motor ( F ) fell 15.1%, which indicates that opinion soured on the business and how attractive it is to own based on either its stock price, or underlying fundamentals, like revenue, which rose 5.62% over the past year.

A complete overview of how Wall Street views individual stocks is available here, while real time updates on the latest analyst actions will be delivered via Benzinga PRO. Try it for free.

F has a 52-week high of $14.85 and a 52-week low of $9.49.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
The Lion Electric Up 3.1% In US Premarket As Makes Additional Amendments to Certain Senior Credit Instruments
The Lion Electric Up 3.1% In US Premarket As Makes Additional Amendments to Certain Senior Credit Instruments
Oct 2, 2024
07:15 AM EDT, 10/01/2024 (MT Newswires) -- The Lion Electric LEV.TO) was at last look up 3.1% in US premarket trade as it announced Tuesday additional amendments to its senior revolving credit agreement with a syndicate of lenders, and its loan agreement with Finalta Capital and Caisse de depot et placement du Quebec. The revolving credit agreement amendments extend the...
Vizsla Silver Up 2% In US Premarket AS Reports Additional Silver, Gold Mineralization at Panuco Project in Mexico
Vizsla Silver Up 2% In US Premarket AS Reports Additional Silver, Gold Mineralization at Panuco Project in Mexico
Oct 2, 2024
07:19 AM EDT, 10/01/2024 (MT Newswires) -- Vizsla Silver ( VZLA ) was at last look up 2% on Tuesday reported drilling results from 11 new drill holes targeting the Copala resource area of the Panuco silver-gold project in Mexico that expanded near-surface mineralization in the area. According to a statement, the reported drill results are from the recently completed...
Shattuck Labs Shares Fall After Halting Development of Potential Leukemia Treatment
Shattuck Labs Shares Fall After Halting Development of Potential Leukemia Treatment
Oct 2, 2024
07:16 AM EDT, 10/01/2024 (MT Newswires) -- Shattuck Labs ( STTK ) shares were down more than 28% in premarket activity Tuesday after disclosing that it was discontinuing its SL-172154 clinical program for the treatment of acute myeloid leukemia and higher-risk myelodysplastic syndromes. The company said that phase 1 clinical trial results did not show clinically meaningful improvements in median...
Merck Acquires Investigational Leukemia Treatment from Curon Biopharmaceutical for $750 Million
Merck Acquires Investigational Leukemia Treatment from Curon Biopharmaceutical for $750 Million
Oct 2, 2024
07:17 AM EDT, 10/01/2024 (MT Newswires) -- Merck ( MRK ) said Tuesday it completed acquiring full global rights to an investigational antibody, CN201, from Curon Biopharmaceutical for about $750 million. CN201 is currently being studied for potential treatment of two different types of leukemia, Merck ( MRK ) said. The transaction's charge will be included in the company's Q3...
Copyright 2023-2026 - www.financetom.com All Rights Reserved